Larson Financial Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$333K Buy
1,507
+883
+142% +$193K 0.01% 753
2026
Q2
$122K Buy
624
+19
+3% +$3.94K ﹤0.01% 1077
2026
Q1
$136K Buy
605
+155
+34% +$38.6K ﹤0.01% 860
2025
Q4
$108K Buy
450
+182
+68% +$46.5K ﹤0.01% 910
2025
Q3
$73.4K Buy
268
+15
+6% +$4.1K ﹤0.01% 1019
2025
Q2
$65.3K Sell
253
-55
-18% -$13.1K ﹤0.01% 974
2025
Q1
$69K Buy
308
+278
+927% +$64.9K ﹤0.01% 900
2024
Q4
$6.86K Sell
30
-36
-55% -$8.67K ﹤0.01% 1589
2024
Q3
$16.1K Buy
66
+62
+1,550% +$13.9K ﹤0.01% 1295
2024
Q2
$766 Hold
4
– – ﹤0.01% 1759
2024
Q1
$792 Hold
4
– – ﹤0.01% 1489
2023
Q4
$688 Buy
+4
New +$615 ﹤0.01% 1531
2023
Q1
– Sell
-25
Closed -$5.2K – 1595
2022
Q4
$5.2K Buy
+25
New +$5.49K ﹤0.01% 1017

Other funds holding RMD

Larson Financial Group's RMD Position: Q3 2026 in Review

Larson Financial Group increased its ResMed (RMD) stake by 142% in Q3 2026, buying an estimated $193K and bringing the position to 1,507 shares worth $333K. The position accounts for 0.01% of the portfolio, ranked #753.

Larson Financial Group first reported a position in RMD in Q4 2022 and has held it in 13 quarters since. 611 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Larson Financial Group held 1,507 shares of ResMed worth $333K as of Q3 2026.
  • Larson Financial Group bought 883 ResMed shares in Q3 2026, an estimated $193K.
  • ResMed made up 0.01% of Larson Financial Group's portfolio in Q3 2026, its #753 holding.
  • Larson Financial Group first reported a position in ResMed in Q4 2022 and has held it in 13 quarters since.
  • 611 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.